Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
....Ratliff. I enjoyed that one.
That’s the first time that I have had three of my shareholding’s affected by one collaboration, and to be honest, I fully expected this to happen knowing the filtration capabilities of affimers.
I see that TW, apart from calling us "thick as sh*t investors", "morons" and "mugs" is now encouraging us to short the stock. What a towrag that bloke is.
No, because I am trading ITM.
Avacta has tried Carclo before when AX1 (Midas) was being developed, but they couldn’t meet the exacting requirements. Maybe the test strip is much easier to produce.
And yet TW says it’s going away. Testing is going to be with us for a very long time, even a way of life.
I’ve met him on a number of occasions and he is a super guy, very bright and shrewd with it. Very safe hands.
You also have to take into consideration that the fundraise Will also allow shelved projects to be brought back on stream, and we do not know what those projects are or how long they will take to become live. Unless you are privy to exactly what Avacta has on the go, I suggest that “nothing between here and cancer” sounds like TW rhetoric.
China now fears a second wave. This isn’t going away in a hurry.
I certainly did. I pared back my other holdings to buy more here, because I’m not sure that this price will be available for much longer.
I consigned this lot to the bin ages ago, now there’s another placing undoubtably followed by the inevitable consolidation, reducing my holding to zilch, worth stuff all and for what?
If you hold AIM shares for more than two years, they are exempt from inheritance tax.
I think that the placing was unforeseen by Avacta. The company is looking for a partner to fast track the Covid 19 “cure” through which would fast track the testing of affimers in humans. This would also fast track the use of affimers in Avacta’s cancer drug delivery tests which would be of huge benefit to Avacta, so I think that a big pharma has requested a “donation” towards the costs of this research as it will help Avacta enormously. Just a thought.
The last thing I want is for Avacta to come off of AIM. At my age, you have to start thinking about inheritance tax.
I bought £10k worth this morning at 174p which I am reasonably pleased with. It may climb back, it may not, but long term is what matters.
Sorry comek2, posted at the same time.
If Affimers are successful, it opens up the $58 billion antibody market, which could be useful long term.
Is anybody concerned about the IP while selling to China? I would be.
In case anybody hasn't replied. The MMs are the Market Makers and their job is to rob you blind and they are very good at it. They decide the sp price and have all sorts of dirty tricks to make you part with your money. One of the worst is called a tree shake. That is where they drop the sp by about 10% to 15% to scare people into selling and to trigger stop losses thereby grabbing shares at a low price. Whenever you see an sp change value, you must ask yourself why are the MMs doing that? With all due respect, before you dabble in the stock market, you must be more clued up as to how it works and what the pitfalls are otherwise you will lose money, and I am speaking from experience. A really useful book to read is (and i can't name it directly) is by a trader with the same name a famous Scotsman and the title is (sic) a dealer without clothes on.
GL.
This may have already been mentioned, but if you have a trading account in joint names with your partner you get twice the Cgt allowance ie. about £22k.